These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10194127)

  • 61. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice.
    Mehta RR; Graves JM; Hart GD; Shilkaitis A; Das Gupta TK
    Breast Cancer Res Treat; 1993; 25(1):65-71. PubMed ID: 8518409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.
    Grell M; Douni E; Wajant H; Löhden M; Clauss M; Maxeiner B; Georgopoulos S; Lesslauer W; Kollias G; Pfizenmaier K; Scheurich P
    Cell; 1995 Dec; 83(5):793-802. PubMed ID: 8521496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia.
    Mitchell PL; Clutterbuck RD; Powles RL; De Lord C; Morilla R; Hiorns LR; Titley J; Catovsky D; Millar JL
    Blood; 1996 Jun; 87(11):4797-803. PubMed ID: 8639851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice.
    Qin Z; van Tits LJ; Buurman WA; Blankenstein T
    Blood; 1995 May; 85(10):2779-85. PubMed ID: 7742538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduction of tumor necrosis factor-alpha bioactivity by a human ovarian epithelial cancer cell line in vitro.
    Sancho-Tello M; Marcinkiewicz JL; Justice WM; Kimler BF; Terranova PF; Hunter VJ
    Am J Obstet Gynecol; 1995 Nov; 173(5):1470-7. PubMed ID: 7503187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The capacity of human malignant B-lymphocytes to disseminate in SCID mice is correlated with functional expression of the fibronectin receptor alpha 5 beta 1 (CD49e/CD29).
    Blase L; Daniel PT; Koretz K; Schwartz-Albiez R; Möller P
    Int J Cancer; 1995 Mar; 60(6):860-6. PubMed ID: 7534750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Matrigel augments xenograft transplantation of meningioma cells into athymic mice.
    Jensen RL; Leppla D; Rokosz N; Wurster RD
    Neurosurgery; 1998 Jan; 42(1):130-5; discussion 135-6. PubMed ID: 9442514
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Augmentation of human leukemic cell invasion by activation of a small GTP-binding protein Rho.
    Fukushima S; Yamada T; Hashiguchi A; Nakata Y; Hata J
    Exp Hematol; 2000 Apr; 28(4):391-400. PubMed ID: 10781897
    [TBL] [Abstract][Full Text] [Related]  

  • 70. N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity.
    Delneste Y; Jeannin P; Potier L; Romero P; Bonnefoy JY
    Blood; 1997 Aug; 90(3):1124-32. PubMed ID: 9242544
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.
    Lu Z; Xie J; Wu G; Shen J; Collins R; Chen W; Kang X; Luo M; Zou Y; Huang LJ; Amatruda JF; Slone T; Winick N; Scherer PE; Zhang CC
    Nat Med; 2017 Jan; 23(1):79-90. PubMed ID: 27941793
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term malignant hematopoiesis in human acute leukemia bone marrow biopsies implanted in severe combined immunodeficiency mice.
    Legrand F; Khazaal I; Peuchmaur M; Fenneteau O; Cavé H; Rohrlich P; Vilmer E; Péault B
    Blood; 1997 Sep; 90(5):2001-9. PubMed ID: 9292535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.
    Thomas KR; Allenspach EJ; Camp ND; Wray-Dutra MN; Khim S; Zielinska-Kwiatkowska A; Timms AE; Loftus JP; Liggitt HD; Georgopoulos K; Tasian SK; James RG; Rawlings DJ
    Leukemia; 2022 Jan; 36(1):42-57. PubMed ID: 34193976
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia.
    Jeha S; Kantarjian H; O'Brien S; Vitek L; Beran M
    Leuk Lymphoma; 1998 Dec; 32(1-2):159-64. PubMed ID: 10037011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
    Uckun FM; Sather HN; Waurzyniak BJ; Sensel MG; Chelstrom L; Ek O; Sarquis MB; Nachman J; Bostrom B; Reaman GH; Gaynon PS
    Leuk Lymphoma; 1998 Aug; 30(5-6):503-14. PubMed ID: 9711913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.
    Michigami T; Nomizu M; Yamada Y; Dunstan C; Williams PJ; Munday GR; Yoneda T
    Clin Exp Metastasis; 1998 Oct; 16(7):645-54. PubMed ID: 9932611
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene.
    Basolo F; Fiore L; Fusco A; Giannini R; Albini A; Merlo GR; Fontanini G; Conaldi PG; Toniolo A
    Int J Cancer; 1999 Jun; 81(6):956-62. PubMed ID: 10362145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of arginase by mouse myeloid leukemic cell differentiation in vitro induced with tumor necrosis factor.
    Kosaka T; Kuwabara M; Endo A; Tamaguchi H; Koide F
    J Vet Med Sci; 1991 Feb; 53(1):53-7. PubMed ID: 1830780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Growth and immortalization of human myeloma cells in immunodeficient severe combined immunodeficiency mice: a preclinical model.
    Rème T; Gueydon E; Jacquet C; Klein B; Brochier J
    Br J Haematol; 2001 Aug; 114(2):406-13. PubMed ID: 11529865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA cytometric and histologic findings in mouse tumors (BP and S 180) with different response to treatment with tumor necrosis factor.
    Rychly J; Knippel E; Krygier-Stojalowska A; Nizze H; Kuchnio M; Kraeft SK
    Acta Oncol; 1990; 29(1):47-51. PubMed ID: 2310603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.